UK Medtech Industry Targets A National Diagnostics Strategy
Executive Summary
NHS England’s Long Term Plan puts much emphasis on better use of diagnostic tools in health-care delivery. The UK medtech industry is now pressing for a strategy to ensure that these technologies are factored into all patient pathways. It says the data derived will be used to improve patient outcomes and system efficiency.
You may also be interested in...
MHRA’s Lee To Give UK Medtech Industry Greater Diagnostics Focus
The UK ABHI has created a new role for a director of diagnostics regulation, which MHRA IVD’s policy adviser Steve Lee will fill later this month.
The New Culture Club: UK NHS Goes Upstream For Care Delivery And Offers New Chances For Medtechs
Hopes are high for the NHS Long Term Plan’s ability to transform health-care delivery and make a potentially unsustainable service fit for the future. There are opportunities for diagnostics, devices and digital providers, but are the resources there to turn the Plan into a success story?
The Sustainability Stakes Are Rising: ‘We Cannot Recycle Our Way Out Of This’
The journey to Net Zero, described as ‘the defining issue of our time,’ will get harder in the coming decade. Failure to keep up the pressure will result in more long-term health conditions, increasing deaths and higher costs. The UK NHS is a Net Zero exemplar globally, but without a systemic approach, its compliance efforts could stutter.